Merck (MRK) PT Raised to $172 at HSBC
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts MRK Hot Sheet
Price: $150.36 +3.93%
Rating Summary:
24 Buy, 8 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Rating Summary:
24 Buy, 8 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Join SI Premium – FREE
HSBC analyst Rajesh Kumar raised the price target on Merck (NYSE: MRK) to $172.00 (from $150.00) while maintaining a Buy rating.
You May Also Be Interested In
- DZ Bank Downgrades Merck (MRK) to Hold
- Insulet Corporation (PODD) PT Raised to $200 at Jefferies
- Merck (MRK) PT Raised to $140 at Freedom Broker
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
